Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
Some of the newer drugs like semaglutide, which is known as Ozempic and Wegovy, and tirzepatide, which is known as Mounjaro and Zepbound these drugs have increased potency
Without PBS subsidy for obesity indications, patients pay full price: Wegovy: approximately $320$450 per month Saxenda: approximately $390$440 per month Mounjaro (off-label for weight loss): approximately $280$750 per month depending on dose PBS listing for obesity indications is an ongoing discussion, with health economists and advocacy groups pushing for subsidised access given the long-term healthcare costs associated with untreated obesity
One way to increase its stability and limit its breakdown is by consuming antioxidants
Higher concentrations may increase results but also increase irritation risk
